TCL Archive The Meeting Worth Lobbying For: A “PRG” For Disease-Specific Review; NCI Plans Six. June 23, 2000
TCL Archive Drug Development: Tivozanib Trial Discontinued Due to Insufficient Enrollment February 7, 2014
TCL Archive Thompson Names Texas Health Official Head Of HHS Center For Faith-Based Initiatives. March 23, 2001
